Synonyms: | |
Status: | Phase 1 |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
UNII: | 2OP4E0GC6V |
Action | Mechanism of Action | Reference |
---|---|---|
ANTAGONIST | HLA-DR antigens-associated invariant chain antagonist | PubMed |
Primary Target | |
---|---|
CD74 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | D015451 | ClinicalTrials |
Lymphoma | 1 | D008223 | ClinicalTrials |
Multiple Myeloma | 1 | D009101 | ClinicalTrials |
Plasmacytoma | 1 | D010954 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 899796-83-9 |
ChEMBL | CHEMBL1743040 |
FDA SRS | 2OP4E0GC6V |
Guide to Pharmacology | 8267 |